(Q36287682)

English

Systematic review and meta-analysis of randomized trials of central nervous system directed therapy for childhood acute lymphoblastic leukemia

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

0 references

Systematic review and meta-analysis of randomized trials of central nervous system directed therapy for childhood acute lymphoblastic leukemia (English)

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

object named as

Ching-Hon Pui

1 reference

Europe PubMed Central

13 August 2017

PMC publication ID

author name string

Sue Richards

1

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Paul Gayon

3

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Childhood Acute Lymphoblastic Leukemia Collaborative Group (CALLCG)

4

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

publication date

12 June 2012

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Pediatric Blood Cancer

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

60

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

2

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

185-195

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461084

30 September 2017

Effectiveness of high-dose methotrexate in T-cell lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: a randomized study by the Children's Oncology Group (POG 9404).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461084

30 September 2017

Meta-analysis of randomised trials comparing thiopurines in childhood acute lymphoblastic leukaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461084

30 September 2017

Glucocorticoid use in acute lymphoblastic leukaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461084

30 September 2017

Long-term results of the pediatric oncology group studies for childhood acute lymphoblastic leukemia 1984-2001: a report from the children's oncology group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461084

30 September 2017

Treating childhood acute lymphoblastic leukemia without cranial irradiation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461084

30 September 2017

Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461084

30 September 2017

Current management and challenges of malignant disease in the CNS in paediatric leukaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461084

30 September 2017

Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461084

30 September 2017

Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic l

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461084

30 September 2017

Accumulation of methotrexate polyglutamates in lymphoblasts is a determinant of antileukemic effects in vivo. A rationale for high-dose methotrexate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461084

30 September 2017

Malnutrition as a prognostic factor in lymphoblastic leukaemia: a multivariate analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461084

30 September 2017

CNS prophylaxis in acute lymphoblastic leukemia: comparison of two methods a Southwest Oncology Group study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461084

30 September 2017

Intrathecal methotrexate versus central nervous system leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461084

30 September 2017

Comparative results of two intensive treatment programs for childhood acute lymphoblastic leukemia: The Berlin-Frankfurt-Münster and Dana-Farber Cancer Institute protocols

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461084

30 September 2017

Long-term results of Tokyo Children's Cancer Study Group trials for childhood acute lymphoblastic leukemia, 1984-1999.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461084

29 June 2018

Evaluation of induction of remission, intensification, and central nervous system prophylactic treatment in acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461084

29 June 2018

Chemotherapy of acute lymphocytic leukemia of childhood

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461084

29 June 2018

Computerized tomography scan findings in children with acute lymphocytic leukemia treated with three different methods of central nervous system prophylaxis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461084

29 June 2018

Long-term evaluation of a CNS prophylaxis trial--treatment comparisons and outcome after CNS relapse in childhood ALL: a report from the Childrens Cancer Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461084

29 June 2018

Central nervous system (CNS) prophylaxis in children with low risk acute lymphoblastic leukemia (ALL).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461084

29 June 2018

Testicular irradiation in childhood lymphoblastic leukaemia. Medical Research Council Working Party on Leukemia in Childhoods

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461084

29 June 2018

Lower incidence of meningeal leukemia when prednisone is replaced by dexamethasone in the treatment of acute lymphocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461084

29 June 2018

Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997-2004).

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24228

21 January 2018

CNS-Directed Therapy for Childhood Acute Lymphoblastic Leukemia: Childhood ALL Collaborative Group Overview of 43 Randomized Trials

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24228

21 January 2018

Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24228

21 January 2018

Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24228

21 January 2018

Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy: a Childrens Cancer Group report.

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24228

21 January 2018

Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24228

21 January 2018

Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24228

21 January 2018

Successful treatment without cranial radiotherapy of children receiving intensified chemotherapy for acute lymphoblastic leukaemia: results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI (ISRC TN 16757172).

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24228

21 January 2018

Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000.

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24228

21 January 2018

Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials. UK Medical Research Council's Working Party on Childhood Leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24228

21 January 2018

Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: randomized controlled trial from the Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24228

21 January 2018

Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report. Children Leukemia Cooperative Group

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24228

21 January 2018

Critical study of prognostic factors in childhood acute lymphoblastic leukaemia: differences in outcome are poorly explained by the most significant prognostic variables. Fralle group. French Acute Lymphoblastic Leukaemia study group.

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24228

21 January 2018

Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber ALL Consortium Protocol 87-01.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461084

22 September 2018

Irradiation, methotrexate toxicity, and the treatment of meningeal leukaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461084

22 September 2018

Treatment of acute lymphoblastic leukemia in the Tokyo Children's Cancer Study Group--preliminary results of L84-11 protocol

1 reference

https://pubmed.ncbi.nlm.nih.gov/22693038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extended triple intrathecal chemotherapy trial for prevention of CNS relapse in good-risk and poor-risk patients with B-progenitor acute lymphoblastic leukemia: a Pediatric Oncology Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22693038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment results of three consecutive Brazilian cooperative childhood ALL protocols: GBTLI-80, GBTLI-82 and -85. ALL Brazilian Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/22693038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of acute lymphoblastic leukemia therapy in childhood with a modified BFM protocol in a multicenter study in the German Democratic Republic

1 reference

https://pubmed.ncbi.nlm.nih.gov/22693038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of standard- and high-risk childhood acute lymphoblastic leukaemia with two CNS prophylaxis regimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/22693038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of two regimens for high-risk acute lymphocytic leukemia in childhood. A Pediatric Oncology Group Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22693038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: a Childrens Cancer Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22693038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intermediate-dose methotrexate versus cranial irradiation in childhood acute lymphoblastic leukemia: a ten-year follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/22693038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: a report from the Children's Cancer Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/22693038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improvement in CNS protective treatment in non-high-risk childhood acute lymphoblastic leukemia: report from the Japanese Children's Cancer and Leukemia Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/22693038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High leucovorin doses during high-dose methotrexate treatment may reduce the cure rate in childhood acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22693038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Very high-dose methotrexate (33.6 g/m(2)) as central nervous system preventive therapy for childhood acute lymphoblastic leukemia: results of National Cancer Institute/Children's Cancer Group trials CCG-191P, CCG-134P and CCG-144P

1 reference

https://pubmed.ncbi.nlm.nih.gov/22693038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term results of the Israeli National Studies in childhood acute lymphoblastic leukemia: INS 84, 89 and 98

1 reference

https://pubmed.ncbi.nlm.nih.gov/22693038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of irradiation in central nervous system treatment and prophylaxis for acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22693038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination chemotherapy and radiotherapy for acute lymphocytic leukemia in adults: Results of CALGB protocol 7113

1 reference

https://pubmed.ncbi.nlm.nih.gov/22693038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of prophylactic treatment of the central nervous system on the intellectual functioning of children with acute lymphocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22693038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medical Research Council leukaemia trial, UKALL VII. A report to the Council by the Working Party on Leukaemia in Childhood

1 reference

https://pubmed.ncbi.nlm.nih.gov/22693038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medical Research Council leukaemia trial--UKALL V: an attempt to reduce the immunosuppressive effects of therapy in childhood acute lymphoblastic leukemia. Report to the Council by the Working Party on Leukaemia in Childhood

1 reference

https://pubmed.ncbi.nlm.nih.gov/22693038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How much is too much? Folinic acid rescue dose in children with acute lymphoblastic leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22693038

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/PBC.24228

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36287682&oldid=1644927982"